NCT04278027 Cognitive Remediation Therapy in Schizophrenia: Effects on Epigenetics Status UNKNOWN Phase NA
NCT04276012 Effectiveness of a Cardiovascular Risk Intervention Program in Patients With Schizophrenia (PRISCA) Status UNKNOWN Phase NA
NCT04268303 Dexmedetomidine in the Treatment of Agitation Associated With Schizophrenia Status COMPLETED Phase PHASE3
NCT04267003 Effects of Brain Stimulation on Cognition, Oscillations and GABA Levels in Schizophrenia Status RECRUITING Phase NA
NCT04252131 Therapeutic Effect of Cassia Seed in Obesity of Patients With Schizophrenia Status COMPLETED Phase PHASE1
NCT04240496 Clinical and Genetic Influencing Factors on Clozapine Pharmacokinetics Status COMPLETED Phase NA
NCT04221269 Suicide Prevention Intervention for Schizophrenia-Spectrum Disorders Status COMPLETED Phase NA
NCT04220099 Electroencephalogram (EEG) and Electroconvulsive Therapy(ECT) Response in Schizophrenia Status COMPLETED Phase N/A
NCT04203056 Aripiprazole Lauroxil for Preventing Psychotic Relapse After an Initial Schizophrenia Episode Status TERMINATED Phase PHASE4
NCT04191200 Oral Status of Patients Suffering From SCHIZophrenia Followed at Charles Perrens Hospital Status COMPLETED Phase N/A
NCT04190004 Effect of Intranasal Vasopressin on Cooperative Behavior in Schizophrenia Status COMPLETED Phase NA
NCT04187560 Safety and Tolerability of Single and Multiple Doses of LB-102 in Healthy Adults Status COMPLETED Phase PHASE1
NCT04184830 Improving Cognition in Schizophrenia Using Non-invasive Brain Stimulation Status COMPLETED Phase NA